References

Alcon, S.;  Talarmin, A.;  Debruyne, M.;  Falconar, A.;  Deubel, V.; Flamand, M., Enzyme-linked immunosorbent assay specific to Dengue virus type 1 nonstructural protein NS1 reveals circulation of the antigen in the blood during the acute phase of disease in patients experiencing primary or secondary infections. J Clin Microbiol 2002, 40 (2), 376-81.

Allonso, D.;  Meneses, M. D.;  Fernandes, C. A.;  Ferreira, D. F.; Mohana-Borges, R., Assessing positivity and circulating levels of NS1 in samples from a 2012 dengue outbreak in Rio de Janeiro, Brazil. PLoS One 2014, 9 (11), e113634.

Anand, A. M.;  Sistla, S.;  Dhodapkar, R.;  Hamide, A.;  Biswal, N.; Srinivasan, B., Evaluation of NS1 Antigen Detection for Early Diagnosis of Dengue in a Tertiary Hospital in Southern India. J Clin Diagn Res 2016, 10 (4), DC01-4.

antibodies-online.com, "Dengue Virus IgM ELISA Kit" https://www.antibodies-online.com/kit/1326831/Dengue+Virus+IgM+ELISA+Kit/?utm_source=partner&utm_medium=biocompare&utm_campaign=non_sponsored&utm_content=kit&utm_term=ABIN1326831 (Accessed on 12/20/2022). 2022.

Balmaseda, A.;  Stettler, K.;  Medialdea-Carrera, R.;  Collado, D.;  Jin, X.;  Zambrana, J. V.;  Jaconi, S.;  Cameroni, E.;  Saborio, S.;  Rovida, F.;  Percivalle, E.;  Ijaz, S.;  Dicks, S.;  Ushiro-Lumb, I.;  Barzon, L.;  Siqueira, P.;  Brown, D. W. G.;  Baldanti, F.;  Tedder, R.;  Zambon, M.;  de Filippis, A. M. B.;  Harris, E.; Corti, D., Antibody-based assay discriminates Zika virus infection from other flaviviruses. Proc Natl Acad Sci U S A 2017, 114 (31), 8384-8389.

Barniol, J.;  Gaczkowski, R.;  Barbato, E. V.;  da Cunha, R. V.;  Salgado, D.;  Martínez, E.;  Segarra, C. S.;  Pleites Sandoval, E. B.;  Mishra, A.;  Laksono, I. S.;  Lum, L. C.;  Martínez, J. G.;  Núnez, A.;  Balsameda, A.;  Allende, I.;  Ramírez, G.;  Dimaano, E.;  Thomacheck, K.;  Akbar, N. A.;  Ooi, E. E.;  Villegas, E.;  Hien, T. T.;  Farrar, J.;  Horstick, O.;  Kroeger, A.; Jaenisch, T., Usefulness and applicability of the revised dengue case classification by disease: multi-centre study in 18 countries. BMC Infectious Diseases 2011, 11 (1), 106.

Bhatt, S.;  Gething, P. W.;  Brady, O. J.;  Messina, J. P.;  Farlow, A. W.;  Moyes, C. L.;  Drake, J. M.;  Brownstein, J. S.;  Hoen, A. G.;  Sankoh, O.;  Myers, M. F.;  George, D. B.;  Jaenisch, T.;  Wint, G. R.;  Simmons, C. P.;  Scott, T. W.;  Farrar, J. J.; Hay, S. I., The global distribution and burden of dengue. Nature 2013, 496 (7446), 504-7.

Bouckenooghe, A.;  Chen, J.;  Ng, S. P.;  Gilbert, P. B.;  Gurunathan, S.; DiazGranados, C. A., Effect of Dengue Serostatus on Dengue Vaccine Safety and Efficacy. N Engl J Med 2018, 379 (4), 327-340.

Brown, J. A.;  Singh, G.;  Acklin, J. A.;  Lee, S.;  Duehr, J. E.;  Chokola, A. N.;  Frere, J. J.;  Hoffman, K. W.;  Foster, G. A.;  Krysztof, D.;  Cadagan, R.;  Jacobs, A. R.;  Stramer, S. L.;  Krammer, F.;  Garcia-Sastre, A.; Lim, J. K., Dengue Virus Immunity Increases Zika Virus-Induced Damage during Pregnancy. Immunity 2019, 50 (3), 751-762 e5.

Caci, J. B.;  Blaylock, J. M.;  De La Barrera, R.;  Griggs, A. N.;  Lin, L.;  Jarman, R. G.;  Thomas, S. J.; Lyons, A. G., Seroprevalence of Dengue Fever in US Army Special Operations Forces: Initial Results and the Way Ahead. J Spec Oper Med 2014, 14 (3), 111-5.

Castellanos, J. E.; Coronel-Ruiz, C., Dengue disease diagnosis: A puzzle to be solved. Revista de la Facultad de Medicina 2014, 62, 617-629.

CDC, "CDC recommends Dengue Testing Guidance" https://www.cdc.gov/dengue/healthcare-providers/testing/testing-guidance.html (Accessed 12/20/2022). 2022.

Center for Disease Control and Prevention (CDC), "Dengue" (https://www.cdc.gov/dengue/index.html, Accessed 12/20/2022).

Darwish, N. T.;  Sekaran, S. D.; Khor, S. M., Point-of-care tests: A review of advances in the emerging diagnostic tools for dengue virus infection. Sensors and Actuators B: Chemical 2018, 255, 3316-3331.

Department of Defense (DOD), "A point-of-care assay to determine soldier dengue exposure and enable rapid, mass, cost-efficient dengue vaccination programs of military personnel" (A19-124) https://www.sbir.gov/sbirsearch/detail/1605905 (Accesed 12/20/2022)

Gibbons, R. V.;  Streitz, M.;  Babina, T.; Fried, J. R., Dengue and US military operations from the Spanish-American War through today. Emerg Infect Dis 2012, 18 (4), 623-30.

Hasan, S. S.;  Sevvana, M.;  Kuhn, R. J.; Rossmann, M. G., Structural biology of Zika virus and other flaviviruses. Nat Struct Mol Biol 2018, 25 (1), 13-20.

Hesse, E. M.;  Martinez, L. J.;  Jarman, R. G.;  Lyons, A. G.;  Eckels, K. H.;  De La Barrera, R. A.; Thomas, S. J., Dengue Virus Exposures Among Deployed U.S. Military Personnel. Am J Trop Med Hyg 2017, 96 (5), 1222-1226.

Lai, S.-C.;  Huang, Y.-Y.;  Shu, P.-Y.;  Chang, S.-F.;  Hsieh, P.-S.;  Wey, J.-J.;  Tsai, M.-H.;  Ben, R.-J.;  Hsu, Y.-M.;  Fang, Y.-C.;  Hsiao, M.-L.; Lin, C.-C., Development of an Enzyme-Linked Immunosorbent Assay for Rapid Detection of Dengue Virus (DENV) NS1 and Differentiation of DENV Serotypes during Early Infection. Journal of Clinical Microbiology 2019, 57 (7), e00221-19.

Modis, Y.;  Ogata, S.;  Clements, D.; Harrison, S. C., Structure of the dengue virus envelope protein after membrane fusion. Nature 2004, 427 (6972), 313-9.

Navarrete-Espinosa, J.;  Cuervo-Hernandez, N. M.; Vazquez-Martinez, J. L., [Hemorrhagic dengue without hemorrhaging: a novel diagnostic category?]. Gac Med Mex 2008, 144 (2), 105-10.

Ngono, A. E.; Shresta, S., Immune Response to Dengue and Zika. Annu Rev Immunol 2018, 36, 279-308.

Priyamvada, L.;  Quicke, K. M.;  Hudson, W. H.;  Onlamoon, N.;  Sewatanon, J.;  Edupuganti, S.;  Pattanapanyasat, K.;  Chokephaibulkit, K.;  Mulligan, M. J.;  Wilson, P. C.;  Ahmed, R.;  Suthar, M. S.; Wrammert, J., Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci U S A 2016, 113 (28), 7852-7.

Rey, J. R., Dengue in Florida (USA). Insects 2014, 5 (4), 991-1000.

Robinson, M.;  Sweeney, T. E.;  Barouch-Bentov, R.;  Sahoo, M. K.;  Kalesinskas, L.;  Vallania, F.;  Sanz, A. M.;  Ortiz-Lasso, E.;  Albornoz, L. L.;  Rosso, F.;  Montoya, J. G.;  Pinsky, B. A.;  Khatri, P.; Einav, S., A 20-Gene Set Predictive of Progression to Severe Dengue. Cell Rep 2019, 26 (5), 1104-1111 e4.

Roushani, M.; Shahdost-Fard, F., A highly selective and sensitive cocaine aptasensor based on covalent attachment of the aptamer-functionalized AuNPs onto nanocomposite as the support platform. Anal Chim Acta 2015, 853, 214-221.

Santiago, G. A.;  Vazquez, J.;  Courtney, S.;  Matias, K. Y.;  Andersen, L. E.;  Colon, C.;  Butler, A. E.;  Roulo, R.;  Bowzard, J.;  Villanueva, J. M.; Munoz-Jordan, J. L., Performance of the Trioplex real-time RT-PCR assay for detection of Zika, dengue, and chikungunya viruses. Nat Commun 2018, 9 (1), 1391.

Shepard, D. S.;  Undurraga, E. A.;  Halasa, Y. A.; Stanaway, J. D., The global economic burden of dengue: a systematic analysis. Lancet Infect Dis 2016, 16 (8), 935-41.

Sridhar, S.;  Luedtke, A.;  Langevin, E.;  Zhu, M.;  Bonaparte, M.;  Machabert, T.;  Savarino, S.;  Zambrano, B.;  Moureau, A.;  Khromava, A.;  Moodie, Z.;  Westling, T.;  Mascarenas, C.;  Frago, C.;  Cortes, M.;  Chansinghakul, D.;  Noriega, F.; 

WHO, "World Health Organization, Dengue and sever dengue" (https://www.who.int/news-room/fact-sheets/detail/dengue-and-severe-dengue, Accessed 12/20/2022). 2022.

WHO, Dengue (Guidelines for Diagnosis, Treatment, Prevention and Control). In Dengue: Guidelines for Diagnosis, Treatment, Prevention and Control: New Edition, Geneva, 2009.

Xu, J.;  Wang, Y.;  Xian, Y.;  Jin, L.; Tanaka, K., Preparation of multiwall carbon nanotubes film modified electrode and its application to simultaneous determination of oxidizable amino acids in ion chromatography. Talanta 2003, 60 (6), 1123-30.

Xu, X.;  Vaughan, K.;  Weiskopf, D.;  Grifoni, A.;  Diamond, M. S.;  Sette, A.; Peters, B., Identifying Candidate Targets of Immune Responses in Zika Virus Based on Homology to Epitopes in Other Flavivirus Species. PLoS Curr 2016, 8.